Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

Innovative Medical

Overview

The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Conditions

Macula Thickening

Interventions

Prednisolone AcetateDRUG

Ketorolac 0.4%DRUG

Gatifloxacin 0.3%DRUG

Eligibility

Sex: ALLMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Males or females \> 50 years old * Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL. * Likely to complete all study visits and able to provide informed consent * Visual potential of 20/25 or better Exclusion Criteria: * · Prior use of topical ketorolac * Known contraindications to any study medication or ingredients * Active ocular diseases or uncontrolled systemic disease * Active ocular allergies

Locations (1)

Ophthalmic Consultants of Long Island

Rockville Centre, New York, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.